Lamotrigine was more effective than carbamazepine, gabapentin, and topiramate for treatment failure in partial epilepsy

November 2007
ACP Journal Club;Nov/Dec2007, Vol. 147 Issue 3, p74
Academic Journal
The article focuses on a clinical study comparing the efficacy of gabapentin (GPT), carbamazepine (CBZ), topiramate (TPM), oxcarbazepine (OXC), and lamotrigine (LTG), in the treatment of patients with partial-onset seizures. It discusses the procedure followed, follow-up period, selection criteria of the patients, and the randomized controlled trials, carried out during the study. It mentions the outcomes of the study and states that lamotrigine was found to be more effective than other drugs.


Related Articles

  • Topiramate versus Carbamazepine for the Treatment of Classical Trigeminal Neuralgia, A Meta-Analysis. Qiang-ping Wang; Min Bai // CNS Drugs;2011, Vol. 25 Issue 10, p847 

    Background: Carbamazepine is currently the drug of first choice in the treatment of trigeminal neuralgia. However, it is reported as efficacious in only 70-80% of patients, and can be associated with adverse effects such as drowsiness, confusion, nausea, ataxia, nystagmus and hypersensitivity,...

  • Influence of Enzyme-Inducing Antiepileptic Drugs on Trough Level of Imatinib in Glioblastoma Patients. Pursche, Stefan; Schleyer, Eberhard; von Bonin, Malte; Ehninger, Gerhard; Said, Samir Mustafa; Prondzinsky, Roland; Illmer, Thomas; Yanfeng Wang; Hosius, Christian; Nikolova, Zariana; Bornhäuser, Martin; Dresemann, Gregor // Current Clinical Pharmacology;Sep2008, Vol. 3 Issue 3, p198 

    Background: Imatinib mesylate is used in combination with hydroxyurea (HU) in ongoing clinical phase II studies in recurrent glioblastoma multiforme (GBM). CYP3A4 enzyme-inducing antiepileptic drugs (EIAEDs) like carbamazepine, phenytoin, and oxcarbazepine -- as well as non-EIAEDs like valproic...

  • Brand Spanking II: Attack of the Clones (or, The Phantom Menace). Mintzer, Scott // Epilepsy Currents;Sep/Oct2016, Vol. 16 Issue 5, p310 

    No abstract available.

  • Oxcarbazepine long-term treatment retention in patients switched over from carbamazepine. Albani, F.; Baruzzi, A. // Neurological Sciences;Jul2006, Vol. 27 Issue 3, p173 

    We evaluated the long-term outcome of oxcarbazepine (OXC) monotherapy in a population of patients switched over from carbamazepine (CBZ) monotherapy. Subjects of the study were recruited among patients who had successfully completed the PRIMO study, a recent multicentre Italian study that...

  • Carbamazepine/lamotrigine.  // Reactions Weekly;2/13/2010, Issue 1288, p10 

    The article focuses on a case of Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS) syndrome attributed to carbamazepine and lamotrigine.

  • Carbamazepine/lamotrigine.  // Reactions Weekly;3/17/2012, Issue 1393, p13 

    The article describes the case of a 53-year-old woman who experienced recurrent agammaglobulinaemia after treatment with carbamazepine and lamotrigine.

  • Carbamazepine/topiramate/valproic acid.  // Reactions Weekly;6/11/2011, Issue 1355, p12 

    The article describes the cases of five paediatric patients with epilepsy who died during treatment with carbamazepine, topiramate and valproic acid.

  • Long-term Tolerability and Efficacy of Lamotrigine in Infants 1 to 24 Months Old. Piña-Garza, Jesús Eric; Elterman, Roy D.; Ayala, Ricardo; Corral, Maria; Mikati, Mohamad A.; Piña-Garza, Mary J.; Warnock, Clay R.; Conklin, Heather S.; Messenheimer, John A. // Journal of Child Neurology;Aug2008, Vol. 23 Issue 8, p853 

    This open-label study was designed to evaluate the long-term tolerability and efficacy of lamotrigine in 1- to 24-month-old infants with partial seizures. The study enrolled both lamotriginenaïve patients and patients who had been previously exposed to lamotrigine in a randomized,...

  • Long-Term Follow-Up of Phentermine with Topiramate for Obesity in a Clinical Practice. Najarian, Thomas // Diabetes;Jun2007 Supplement 1, Vol. 56, pA691 

    Effective and well-tolerated treatments are needed for obesity. Low-dose phentermine with topiramate has shown promise in treating obesity in a 24-week, double-blind, randomized trial with 11.4% lit weight loss and only 2% withdrawals due to side effects and 8% overall non-completers in the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics